Drugs / Extended Phenytoin Sodium
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | EXTENDED PHENYTOIN SODIUM | — | 1986-12-18 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04956627 | Jul 2021 → Apr 2022 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Extended Phenytoin Sodium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04956627 ↗ |